代表性成果 (論文/專利/專著等) |
1. Gao WR, Hu XH, Yu KY, Cai HY, Wang ZJ, Wang L*, Wu MN*. Selective Orexin 1 Receptor Antagonist SB-334867 Aggravated Cognitive Dysfunction in 3xTg-AD Mice. Behav Brain Res. 2023. 438: 114171. 2. Li YY, Yu KY, Cui YJ, Wang ZJ, Cai HY, Cao JM *, Wu MN*. Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism. Neurobiol Aging. 2023, 124: 71-84. 5.133 3. Li Y#, Chen R#, Shen GP, Yin J, Li Y, Zhao J, Nan F, Zhang SH, Zhang HF, Yang CH, Wu MN*, Fan YY*. Delayed CO2 postconditioning promotes neurological recovery after cryogenic traumatic brain injury by downregulating IRF7 expression. CNS Neurosci Ther. 2023, 29 (11): 3378-3390. 4. Wang ZJ#*, Li XR#, Chai SF, Li WR, Li S, Hou M, Li JL, Ye YC, Cai HY, Hölscher C, Wu MN*. Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway. Neuropharmacology. 2023, 240: 109716. 5. Yin J, Tuo CM, Yu KY, Hu XH, Fan YY*, Wu MN*. Diurnal Characteristics of the Orexin System Genes and Its Effects on Pathology at Early Stage in 3xTg-AD Mice. Neuromolecular Med. 2023, 25(4):632-643. 6. Cai HY#, Hou SJ#, Wen R, Feng QF, Xi YJ, Zhang SX, Qiao J, Wu MN*. Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study. J Alzheimers Dis. 2023, 94 (4): 1477-1485. 7. Cai HY#*, Chen SR#, Wang Y, Jiao JJ, Qiao J, Hölscher C, Wang ZJ, Zhang SX, Wu MN*. Integrated analysis of the lncRNA-associated ceRNA network in Alzheimer's disease. Gene. 2023, 876: 147484. 8. Hu XH#, Yu KY#, Li XX, Zhang JN, Jiao JJ, Wang ZJ, Cai HY, Wang L, He YX*, Wu MN*. Selective Orexin 2 Receptor Blockade Alleviates Cognitive Impairments and the Pathological Progression of Alzheimer's Disease in 3xTg-AD Mice. J Gerontol A Biol Sci Med Sci. 2024, 79 (7): glae115. 9. Ye YC, Fu CJ, Li Y, Sun JL, Li XR, Chai SF, Li S, Hou M, Cai HY, Wang ZJ*, Wu MN*. Alternate-day fasting improves cognitive and brain energy deficits by promoting ketone metabolism in the 3xTg mouse model of Alzheimer's disease. Exp Neurol. 2024. 381: 114920. 10. Jiao JJ, Hu Y, Cui YJ, Tuo CM, Wang YX, Li XY, Zhang Y*, Wu MN*. Anisomycin alleviates cognitive impairments and pathological features in 3xTg-AD mice. Neuropharmacology. 2024.261:110159. 11. Wang ZJ#, Han WN#, Chai SF, Li Y, Fu CJ, Wang CF, Cai HY, Li XY, Wang X, Hölscher C*, Wu MN*. Semaglutide promotes the transition of microglia from M1 to M2 type to reduce brain inflammation in APP/PS1/tau mice. Neuroscience. 2024, 563: 222-234. |